Locus Biosciences

Phagos

The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.

Algen Biotechnologies

This company develops a CRISPR and artificial intelligence platform to discover drugs for pharmaceutical partners and its own therapeutic pipeline.

Phaxiam

The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.

Ancilia Bio

The company develops CRISPR-engineered bacterial therapies with viral immunity for the biopharmaceutical and healthcare sectors.

Felix Biotech

Felix Biotechnology develops engineered bacteriophage therapies to treat drug-resistant bacterial infections for patients with chronic diseases and partners in the skin care industry.

BiomX

This clinical-stage biotechnology company develops natural and engineered bacteriophage cocktails to treat chronic bacterial infections and inflammatory diseases for healthcare providers and patients.

Sherlock Biosciences

This company develops molecular diagnostic tests using CRISPR and synthetic biology for healthcare providers and consumers to detect infectious diseases and other health conditions.

EcoPhage

This company develops bacteriophage-based biopesticides to manage bacterial diseases in crops for the agricultural industry.